# OnCo record eclipse-shield (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eclipse-shield/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eclipse-shield", "NCT04136002" ;
  schema:name "ECLIPSE (Shield blood test)"@en ;
  schema:description "The study behind the first approved blood test for bowel cancer screening: it found 83% of cancers but only 13% of advanced polyps."@en ;
  schema:url <https://onco.cc/trials/eclipse-shield/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04136002>, <https://doi.org/10.1056/NEJMoa2304714>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P230009> ;
  onco:status "positive" ;
  onco:phase "observational" ;
  schema:startDate "2019-10-08" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/colorectal-screening/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/shield/> ;
  onco:companies <https://onco.cc/companies/guardant-health/> ;
  onco:terms <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/sensitivity-specificity/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-eclipse-shield-n-engl-j-med-2024/> .